Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Journal of Thrombosis and Haemostasis : JTH|August 21, 2009
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysisS G Chu, R C Becker, P B Berger, et al.Journal of the American College of Cardiology|July 1, 1997
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial InfarctionJ S Hochman, C H McCabe, P H Stone, et al.Journal of the American College of Cardiology|May 1, 1996
A composite view of cardiac rupture in the United States National Registry of Myocardial InfarctionR C Becker, J M Gore, C Lambrew, et al.Journal of Thrombosis and Haemostasis : JTH|August 21, 2009
Platelet functions beyond hemostasisS S Smyth, R P McEver, A S Weyrich, et al.Journal of Thrombosis and Thrombolysis|April 20, 2011
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial designT J Povsic, M G Cohen, M Y Chan, et al.Physical Review Letters|May 21, 2010
Viscous Rayleigh-Taylor instability experiments at high pressure and strain rateHye-Sook Park, K T Lorenz, R M Cavallo, et al.American Heart Journal|January 8, 1999
A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium InvestigatorsR C Becker, S P Ball, P Eisenberg, et al.Journal of the American College of Cardiology|April 1, 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trialC P Cannon, C H McCabe, T D Henry, et al.The American Journal of Cardiology|April 4, 1998
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial IschemiaS Borzak, C P Cannon, P L Kraft, et al.Journal of Clinical Pharmacology|March 27, 2014
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AFI G Girgis, M R Patel, G R Peters, et al.Pageof 11